Karla Flores was diagnosed with a rare brain tumor. An misplaced MRI found a second, nearly inoperable, tumor on her spine.

A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...

Today some of the most aggressive solid tumor cancers remain stubbornly resistant to treatment. There are many reasons why ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

Clinical and molecular determinants of survival in pancreatic neuroendocrine tumors: A comprehensive analysis from SEER and TCGA databases.

Genomic characterization of STAS in stage 1 EGFR-mutated NSCLC and prognostic implications.

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...